Hypertension (HTn) is a prevalent and important risk factor for both cardiovascular and all-cause mortality. Depression is often present in hypertensive patients and has also been associated with increased mortality risk. The aim of this study was to evaluate the association of depressive symptoms with all-cause mortality and ischemic heart disease (IHD) mortality among adults with self-reported HTn.
january 2010 | VOLuME 23 nuMBEr 1 | 30-37 | AMERICAN JOURNAL OF HYPERTENSION nature publishing group original contributions Hypertension (HTN) is extremely prevalent in the United States affecting over 65 million people, ~29% of the adult population. 1,2 HTN remains a cardinal predictor of cardiovascular disease events, stroke, and death. 3 Similarly, it is associated with increased morbidity and health-care costs. Druss et al. estimated that hypertensive patients accumulated almost twice the per capita health-care costs when compared to other chronic conditions including mood disorders, diabetes, heart disease, and asthma. 4 Total health costs for patients with HTN were over $110 billion in 1996.
Depression is highly prevalent in the United States, affecting an estimated 14.8 million adults or about 6.7% of the US population above age 18 in a given year. 5 According the World Health Organization, unipolar major depression was the second leading cause of disability-adjusted life years lost among US women in 1996 and the fifth leading cause for all people worldwide in 1999 (ref. 6 ). In addition to causing substantial disability, diminished work productivity and absenteeism, depression is associated with increased use of health-care resources. 7 Multiple studies have demonstrated that depression is associated with increased all-cause mortality including cardiovascular mortality. [8] [9] [10] [11] [12] [13] Earlier work by our group has also demonstrated a significantly increased risk of death in patients with comorbid depression and diabetes. 14 Studies to date have failed to address the specific association between comorbid depression and overall and ischemic heart disease (IHD) mortality in adults with HTN. To address these issues, we examined mortality in a large nationally representative cohort of adults aged 25-75 years in 1971-1975 , who were reinterviewed in 1982 and followed until 1992 (refs. [14] [15] [16] . We compared all-cause mortality among four subsets of participants based on their disease status at the 1982 interview.
Methods
The National Health and Nutrition Examination Survey (NHANES) I was a multistage, stratified, national probability sample of the civilian noninstitutionalized population of the United States aged 1-74 years (ref. 17) . Initially conducted in1971 and 1975, it included a standardized examination original contributions Hypertension, Depression, and Mortality and questionnaires that addressed various health topics. Persons living in poverty areas, women of childbearing age (25-44 years) , and elderly persons (>65 years) were oversampled. Seventy percent (14,407 of 20,729 persons) of the NHANES I cohort were medically examined. The NHANES I Epidemiologic Follow-up Study (NHEFS) is a longitudinal study of participants who were between 25 and 74 years old during the 1971-1975 interviews. 15, 16 The first follow-up study was conducted in 1982 and included all persons aged 5-74 years at the NHANES I assessment (n = 14,407). Participants were subsequently interviewed in 1986, 1987, and 1992. The 1982 follow-up interview included data on self-reported medical conditions and an assessment of depression based on the Center for Epidemiologic Studies Depression Scale (CES-D). For this investigation, we analyzed data on participants in the NHEFS cohort who completed the CES-D in 1982 and were followed until the 1992 interview date.
Definitions of HTN and depression. Self-reported HTN was based on a "yes" response to the question, "Have you ever been told by a doctor that you have hypertension?" Although this question does not equate to a diagnosis of HTN, it has been validated as a screen for HTN in epidemiologic studies. [18] [19] [20] A positive screen for depression in the NHEFS study was defined using the CES-D, a validated self-report scale for assessing depression in the general population. 21 The scale consists of 20 items rated on a four-point scale with response categories indicating the frequency of occurrence of each item in the previous week. The four-point scale ranges from 0 (rarely or none of the time) to 3 (most or all of the time). Scores for items 4, 8, 12, and 16 are reversed before scores for the 20 items are summed. Total scores range from 0 to 60 with higher scores indicating more depressive symptoms. A cutoff of ≥16 has been used extensively for distinguishing depressed from nondepressed patients. The CES-D is a valid and reliable instrument for assessing depression in community samples with high internal consistency, good construct and concurrent validity, and modest test-retest reliability. [21] [22] [23] [24] Defining the study cohort. We defined our cohort as the 10,025 individuals who were alive and interviewed in 1982 and who had complete data for the CES-D. Of the 14,407 respondents eligible for inclusion in the 1982 follow-up study, 13,383 were traced, 11,361 were living, and 10,523 were interviewed. 16 We excluded 498 individuals who either did not have complete data for the CES-D or were missing data for covariates. We divided the cohort into four groups based on the presence or absence Baseline data collection. Demographic, lifestyle behavior, and comorbidity information were collected as part of the 1982 interview. We included age (in years) as a continuous variable. Race/ethnicity was categorized as white vs. black/ other. Poverty/income ratio was defined as percentage of the US federal poverty level and classified as <125, 125-399, and ≥400%. Education was categorized as <high-school graduate, high-school graduate, or >high-school graduate, and marital status was classified as not married or married. BMI was calculated from self-reported weight and height and categorized as normal weight (18.5-24.9), overweight (25.0-29.9), and obese (≥30.0). Smoking was grouped as never, former, or current smoker, and physical activity based on the individual's engagement in usual recreational activity was categorized as regular, light, or sedentary. Self-reported aspirin use was dichotomized as yes vs. no. In addition, respondents were asked to report previously diagnosed medical conditions, including diabetes, heart disease, stroke, and cancer.
Outcome measures. The main outcome measures were allcause mortality and IHD mortality across the four groups in the cohort. Follow-up data were collected in four waves: 1982-1984, 1986, 1987, and 1992 . For each wave, patient or proxy interviews were conducted and health-care facility records as well as death certificates were obtained. Death for each cohort member was ascertained through a search of the National Death Index or through tracing of vital status via a proxy interview. The reliability of the National Death Index for epidemiological studies has been previously validated. 25, 26 Length of follow-up for each individual was calculated from the date of the baseline interview (1982) (1983) (1984) to either the date of death or the date of last follow-up at which patients without confirmed death were presumed alive and lost to follow-up.
Statistical analysis. Statistical analysis was performed with SAS 27 and SUDAAN 28 and the approach recommended by the National Center for Health Statistics for analyzing the NHEFS was used. 29 Means or proportions of baseline risk factors were calculated for the reference group (No HTN/No DEP) and the other three groups (No HTN/DEP, HTN/No DEP, and HTN/DEP). All-cause mortality rates per 1,000 person-years of follow-up were calculated for the four groups. Life expectancy and survival times for the four groups were estimated by the Kaplan-Meier product-limit method. Cox proportional hazards regression models were used to calculate multivariate-adjusted HRs of death for each group compared with the reference group (model 1). A series of sequential multivariate explanatory models were developed that included potentially confounding sociodemographic and clinical variables. Model 2 incorporated sociodemographic variables suspected of influencing the outcomes for hypertensive patients. Model 3 incorporated variables for lifestyle and behavioral variables such as physical activity, smoking, and aspirin use. Model 4 incorporated adjustments for comorbid illnesses including diabetes mellitus, cancer, stroke, and coronary heart disease. Similar models were developed with IHD as the outcome of interest. We performed post hoc tests to assess for interaction between original contributions Hypertension, Depression, and Mortality self-reported HTN and high CES-D score. We also developed models using HTN/DEP as the reference group to determine whether hazard ratios for death from all causes and from IHD were significantly different between the HTN/DEP and HTN/ No DEP groups. The assumption of proportionality of hazard was assessed for the four HTN/depression classification groups and each study covariate; all multivariate models satisfied this assumption.
results
In this nationally representative sample of 10,025 adults followed for an average duration of 8 years (83,943 person-years of follow-up), 1,925 (19%) of the study subjects died. Table 1 shows the baseline characteristics of the study participants. In general, the group of individuals with both HTN and depression were older, included more women, included more ethnic minorities, were more likely to have sedentary lifestyles, more likely to be 48 (1.19, 1.85)  1.45 (1.16, 1.82)  1.35 (1.09, 1.67) Hypertension, not depressed 0.95 (0.86, 1.05) 1.23 (1.08, 1.40)  1.25 (1.09, 1.42)  1.19 (1.05,1.35) Hypertension, depressed 1.12 (0.98, 1.29) 1.69 (1.41, 2.02)  1.61 (1.32, 1.95)  1.39 (1.14, 1.69 overweight/obese, and more likely to have history of depression, heart disease, and stroke at baseline compared with the other three groups. Individuals with both HTN and depression also tended to be poorer, less educated, and less likely to be married at baseline compared with individuals in the other three groups. Tests for interaction between self-reported HTN and CES-Dpositive for depressive symptoms were performed in all models (1) (2) (3) (4) , and no significant interactions were found using product terms. In post hoc analyses individuals with HTN and no depression (HTN, No DEP) had a significantly lower adjusted hazard ratio for death from all causes compared to those with HTN and comorbid depression (HTN, DEP) (HR 0.85, 95% CI 0.73-1.00). Table 3 presents models for the multivariate-adjusted HRs of death from IHD. Model 1 presents unadjusted HRs for IHD mortality. After incorporation of sociodemographic variables (model 2), the HRs for all comparison groups were statistically higher than the reference group, but the highest HR was 2.00 (95% CI 1.39, 2.87) observed in the HTN/DEP group. After incorporation of lifestyle and behavioral variables (model 3), the HRs for the No HTN/DEP and the HTN/ DEP groups were slightly attenuated at 1.67 (95% CI 1.08, 2.58) and 1.86 (95% CI 1.29, 2.69), respectively. Finally, after incorporation of comorbid disease variables into the model (model 4), the HRs for the No HTN/DEP, HTN/No DEP, and HTN/DEP groups were all attenuated at 1.54 (95% CI 1.01, 2.36), 1.38 (95% CI 1.04, 1.84), and 1.59 (95% CI 1.08, 2.34), respectively. Tests for interaction between self-reported HTN and CES-D-positive for depressive symptoms were performed in all models (1) (2) (3) (4) , and no significant interactions were found using product terms. In post hoc analyses, the point estimate for the adjusted hazard ratio for individuals with HTN and no depression (HTN, No DEP) compared to those with HTN and comorbid depression (HTN, DEP) trended lower, but this was not statistically significant (HR 0.87, 95% CI 0.63-1.20). discussion This is the first study to compare the specific association of depressive symptoms with all-cause and IHD mortality in people with HTN using a nationally representative data set that incorporates adjustment for comorbid diseases. The study provides evidence that over a mean follow-up period of 8 years, the coexistence of HTN and depressive symptoms is associated with significantly increased risk of death from all causes. The strength of this association was diminished somewhat after controlling for sociodemographic, behavior/lifestyle, and comorbid disease variables in sequential multivariate-adjusted models. However, even after adjusting for clinically relevant confounders, people with self-reported HTN still had a significant 15% lower relative hazard for death when compared to the group with both self-reported HTN and depressive symptoms.
We observed similar trends toward increased IHD mortality in patients with comorbid HTN and depression, but this did not reach statistical significance. There are several potential reasons for this observation. First, the smaller number of IHD deaths may have limited our power to observe a difference in IHD mortality between the two groups. Second, it is possible that a significant number of patients evaluated in 1982 may have been classified as nonhypertensive who would be considered hypertensive based on current guidelines. The second iteration of guidelines published by the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure that were in effect at 65 (1.47, 1.85 BMI, body mass index; CI, confidence interval; HR, hazard ratio. a The reference group for models 1-4 is patients without self-reported hypertension or depressive symptoms. In separate analysis using variables from model 4 but altering the reference group to those with self-reported hypertension and without depressive symptoms, the adjusted HR for all-cause mortality was 0.85 (95% CI 0.73-1.00).
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Hypertension, Depression, and Mortality 76 (1.14, 2.73)  1.67 (1.08, 2.58)  1.54 (1.01, 2.36) Hypertension, not depressed 1 .16 (0.94, 1.44)  1.45 (1.11, 1.91)  1.46 (1.09, 1.94)  1.38 (1.04, 1.84) Hypertension, depressed 1.33 (1.00, 1.77)  2.00 (1.39, 2.87)  1.86 (1.29, 2.69)  1.59 (1.08, 2.34) age in 1982 (years) 0 .87 (0.85, 0.88)  0.86 (0.85, 0.88)  0.85 (0.84, 0.87 1,32 ). If a significant proportion of hypertensive patients were included in the "no HTN group", then this would tend to minimize the risk difference between the two groups. Additionally, there may have been crossover between groups if patients developed HTN during the 8-year follow-up. If "contamination" and crossover were significant, this may explain why there was also no difference in cardiovascular mortality between the group of hypertensive individuals with and without comorbid depression. Anda et al. previously described a relationship between symptoms of depressed affect/hopelessness and subsequent IHD morbidity and mortality in the NHANES I NHEFS study cohort. These investigators found that the relative risk of fatal IHD was 1.5 (95% CI 1.0, 2.3) for depressed affect, and 1.6 (95% CI 1.0, 2.5) for feelings of hopelessness using items from the General Well-Being Schedule depression sub-scale (GWB-D). A separate group has reported a significant correlation between positive screen for depressive symptoms on GWB-D and CES-D (0.71, P < 0.01) in the NHANES I NHEFS cohort. 33 NHEFS patients received the CES-D and two items of the GWB-D during follow-up interviews, and 83 and 89% of patients were classified in the same (depressed/nondepressed) category on follow-up exam by the CES-D and GWB, respectively.
Our report differs from the prior report by Anda et al. in several important ways. First, our analysis uses the CES-D in place of the GWB depression scale. The CES-D has better reported sensitivity and specificity for the diagnosis of all depressive syndromes when compared to the gold standard structured clinical exam. [21] [22] [23] [24] Second, our analysis also looks at all-cause mortality in addition to IHD mortality. Third, Anda et al. did not include HTN in their models. In fact, they specifically excluded respondents with baseline comorbid coronary artery disease/angina pectoris, diabetes mellitus, stroke, and congestive heart failure from their sample.
It is important for clinicians to appreciate the risk of comorbid depression in their patients with HTN for several reasons. First, depression has been shown to be a predictor of incident HTN. 34 Second, depression has been shown to adversely affect adherence to medical therapy for HTN. 35, 36 This study supports the notion that there is an additional mortality risk associated with comorbid HTN and depression. The biologic mechanisms underlying this observed association are not clear, but it is possible that increased burden of chronic diseases including depression may contribute to increased allostatic load in affected patients. 37 Finally, there is emerging evidence that integrated treatment strategies that target both HTN and depression simultaneously are safe and have the potential to improve outcomes in primary care and subspecialty settings. [38] [39] [40] [41] The approach in this study has several strengths in that it features a large, nationally representative sample prospectively followed for a relatively long interval with available information on key risk factors. This approach does have some limitations. First, data were based on self-report, which might allow misclassification. However, available evidence suggests that self-reported information on chronic diseases and cardiovascular risk factors are accurate. 18, 20, [42] [43] [44] Second, the diagnosis of depression was not based on clinical interview, the gold standard for diagnosis. However, the CES-D is a well-validated and accepted tool for use in screening large populations for depression. [21] [22] [23] [24] Third, it is possible that there was some misclassification of HTN status given the evolution of our understanding of HTN risk and diagnostic guidelines over time. As discussed above, this phenomenon, if present, would tend to underestimate the between-group differences. Another important limitation of this study is the lack of information regarding the severity of HTN in this data set given that the degree of both systolic and diastolic BP elevation has a linear relationship to cardiovascular disease risk and mortality. 45 In summary, both HTN and depression are highly prevalent conditions conferring significant risk for overall morbidity and mortality. This analysis of data from a nationally representative sample of adults with prospective follow-up helps to confirm BMI, body mass index; CHD, coronary heart disease; CI, confidence interval; HR, hazard ratio; IHD, ischemic heart disease. a The reference group for models 1-4 is patients without self-reported hypertension or depressive symptoms. In a separate analysis using variables from model 4 but altering the reference group to those with self-reported hypertension and without depressive symptoms, the adjusted HR for IHD mortality was 0.87 (95% CI 0.63-1.20).
Hypertension, Depression, and Mortality this fact. This analysis further suggests that among patients with self-reported HTN, comorbid depressive symptoms are associated with increased all-cause mortality. This has significant implications for health-care providers who will want to identify comorbid HTN and depression and institute treatment plans for both conditions. acknowledgments: Dr axon and Dr Egede receive funding support from the Department of Veterans affairs research Enhancement award Program.
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